Mucopolysaccharidosis

This page contains recent news articles, when available, and an overview of Mucopolysaccharidosis but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

News: Mucopolysaccharidosis

Vials of 5 Genzyme Drugs for Rare Diseases May Be Tainted  -  ‎Nov 21, 2009‎
Citizens Report...of Gaucher disease, Fabrazyme for Fabry disease, Myozyme for Pomp disease, Aldurazyme for mucopolysaccharidosis and Thyrogen for thyroid cancer. ...

Five Genzyme products for rare diseases found contaminated, but not a big danger  -  ‎Nov 15, 2009‎
Los Angeles TimesThe five drugs are Cerezyme, used to treat Gaucher disease; Fabrazyme, for Fabry disease; Myozyme, for Pompe disease; Aldurazyme, for mucopolysaccharidosis; ...

BioMarin 3Q profit jumps improved drug sales  -  ‎Oct 28, 2009‎
ForbesBoth drugs treat mucopolysaccharidosis I, an inherited metabolic disease that can cause tissue damage and mental retardation. Aldurazyme is sold by Genzyme ...

BioMarin to Present at the Credit Suisse Healthcare Conference  -  ‎Nov 4, 2009‎
ReutersApproved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; ...

Particles Detected in Vials from Genzyme's Plant Not Expected to Impact ...  -  ‎Nov 13, 2009‎
PR Newswire (press release)Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; ...

BioMarin to Present at the Oppenheimer Healthcare Conference  -  ‎Oct 27, 2009‎
ReutersApproved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; ...

BioMarin Pharmaceuticals Announce Acquisition of Huxley  -  ‎Oct 27, 2009‎
TransWorldNews (press release)Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; ...

More contamination troubles for Genzyme  -  ‎Nov 15, 2009‎
Boston Globe...which treats mucopolysaccharidosis, a metabolic disorder; and Thyrogen, which treats thyroid cancer. Cerezyme and Fabrazyme are manufactured in Allston, ...

United States Patent Office Issues Patent Covering the Approved Administration ...  -  ‎Nov 5, 2009‎
ReutersApproved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; ...

To help healing, doctors pay more attention to pain  -  ‎Nov 16, 2009‎
89.3 KPCCErica Thiel, 26, who has a rare genetic disorder involving enzyme deficiency called mucopolysaccharidosis I (MPS I), fell victim to those misconceptions for ...

Patents Issued Covering Stable Tablet Formulation and Once Daily ...  -  ‎Jul 30, 2009‎
PR Newswire (press release)Approved products include Naglazyme(R)( )(galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin;

BioMarin Announces Second Quarter 2009 Financial Results  -  ‎Jul 30, 2009‎
PR Newswire (press release)Net product revenue from Naglazyme (galsulfase), an enzyme replacement therapy for mucopolysaccharidosis VI (MPS VI), was $42.9 million for the second

BioMarin Pharmaceutical Inc. (BMRN) CEO Jean Jacques Bienaime ...  -  ‎Aug 11, 2009‎
GuruFocus.comThe company completed a six-month evaluation of patients being treated with BioMarin\'s lead product BM101 for the treatment of mucopolysaccharidosis-I or

Where Drugs Come From, and How. Once More, With A Roll of the Eyes  -  ‎Jul 31, 2009‎
CoranteMucopolysaccharidosis I? People who actually know something about the drug industry will be nodding their heads, though, because they'll have caught on that

BUYINS.NET: PEP, MO, GENZ, ISRG, STLD, OSIP Expected To Be Higher ...  -  ‎Jul 20, 2009‎
Trading Markets (press release)...and Aldurazyme for the treatment of Mucopolysaccharidosis I. This segment markets and sells its products directly to physicians, hospitals,

BUYINS.NET: STRA, SCG, BMRN, THG, DLB, TEN Expected To Be Higher ...  -  ‎Jul 28, 2009‎
TMC Net...a recombinant form of N-acetylgalactosamine 4-sulfatase enzyme used to treat genetic disease called mucopolysaccharidosis (MPS)VI; Kuvan (sapropterin

배아-태아 유전?검사 139종으로 확대  -  ‎Jul 29, 2009‎
코메디닷컴...검사 결과 유전질환? ?액다당질?(Mucopolysaccharidosis)임? 확?했다. 착? 전 검사를 통해 ? 질환? 없는 정??? 아?? 출산? ??하고 있다.

BioMarin wins Brazilian approval for mucopolysaccharidosis drug  -  06 Feb 2009
Pharmaceutical Business ReviewAs the first drug approved for mucopolysaccharidosis VI, the FDA and EC have both designated Naglazyme as an orphan drug, conferring seven years of market

Galsulfase Approved in Brazil for the Treatment of ...  -  Feb 3, 2009
DG NewsBrazil's National Health Surveillance Agency (ANVISA) has approved galsulfase (Naglazyme) for the treatment of patients with mucopolysaccharidosis VI.

BIOMARIN PHARMACEUTICAL INC  -  Feb 4, 2009
Lifescience-online,The company offers Aldurazyme for the treatment of mucopolysaccharidosis I, a progressive and debilitating life-threatening genetic disease that frequently

BioMarin to Host Fourth Quarter and Full Year 2008 Financial ...  -  Jan 28, 2009
PR Newswire (press release),Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin;

Results From Phase 2 Clinical Study of 6R-BH4 in Peripheral ...  -  Feb 3, 2009
PharmaLive.com (press release),Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin;

Progressive acetabular dysplasia in a boy with ...  -  Dec 22, 2008
7thSpace Interactive (press release),Morquio syndrome is an autosomal recessive lysosomal storage disorder, a mucopolysaccharidosis (PMS), characterized by abnormal metabolism of

Kuvan Receives Marketing Approval in the European Union  -  Dec 9, 2008
Earthtimes (press release),Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin;

BUYINS.NET: Market Maker Surveillance Report. Top 6 Winning Stocks ...  -  Dec 4, 2008
Trading Markets (press release),...and Aldurazyme, a recombinant form of the human enzyme alpha-L-iduronidase to treat mucopolysaccharidosis I. The Transplant segment offers Thymoglobulin

Von Memertys dance through Joburg  -  Dec 4, 2008
Joburg,Thirteen-year-old Oscar, whose battle with the disease mucopolysaccharidosis type 6, or MPS 6, made headlines a few years back, almost brought down the

BioMarin and Summit Plc Sign Worldwide Licensing Agreement for ...  -  Jul 22, 2008
RedOrbit,Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin;

BioMarin and Summit plc Sign Worldwide Licensing Agreement for ...  -  Jul 22, 2008
Earthtimes (press release),Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin;

BioMarin to Host Second Quarter 2008 Financial Results Conference ...  -  Jul 15, 2008
CNNMoney.com (press release)Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin;

Two share 2008 Spector Prize  -  Jul 17, 2008
Washington University Record,Metcalf's thesis was titled "Excessive Phosphorylation of STAT1 Leads to Reduced Chondrocyte Proliferation and Shortened Bones in Mucopolysaccharidosis VII.

Money couldn't save our David  -  Jun 28, 2008
Melbourne Herald Sun,The disease - a strand of mucopolysaccharidosis - is characterised by the gradual deterioration of the brain and body. Because of a missing enzyme,

Firm thrives making drugs for rare conditions  -  Jul 12, 2008
San Francisco Chronicle,The devastating genetic disorder is called mucopolysaccharidosis I, or MPS I. It distorts the bone structure and causes hearing loss, mental retardation and

Watermelon sold at fireworks show to help officer's son  -  Jul 3, 2008
AZ Central.com,Three-year-old Michael "Trey" Lane of Chandler suffers from a rare enzyme deficiency disorder known as mucopolysaccharidosis VI or MPS VI, which means he

Biopten (Sapropterin Dihydrochloride) Approved by Japanese ...  -  Jul 16, 2008
Earthtimes (press release),Approved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin;

AMT Appoints Director Global Marketing and Sales  -  Jul 17, 2008
FOXBusinessShe successfully launched the orphan product Aldurazyme(R) (laronidase) for Mucopolysaccharidosis I in Europe and the Middle East and as Director European

AMT Appoints Director Global Marketing and Sales  -  Jul 16, 2008
SunHerald.com,She successfully launched the orphan product Aldurazyme(R) (laronidase) for Mucopolysaccharidosis I in Europe and the Middle East and as Director European

Dwarves need US medical care, but can't work here legally  -  Jul 10, 2008
Napa Valley Register,Only a few hundred people in the world have their genetic condition, Mucopolysaccharidosis VI, Maroteaux-Lamy, Betsy said. Until the enzyme therapy tested

UK’s BioFusion Expands Sheffield Pact, Raises $4.2M, Changes Name  -  Jul 9, 2008
Biotech Transfer Week,...market, sell, use the licensed products in the field of enzyme replacement therapy compositions for patients with mucopolysaccharidosis IVA, or MPS IVA.

Getting better all the time  -  Jul 3, 2008
Yorkshire Evening Post,Oliver was diagnosed with mucopolysaccharidosis (MPS) VI, one of the world's rarest illnesses, aged four. The disorder results in a build-up of chemicals in

Family: a life sentence worth celebrating  -  Jul 1, 2008
Tonight,...both of their children, Valeska and Oscar, had been diagnosed with the fatal and debilitating disease known as Mucopolysaccharidosis type 6 or MPS 6.

S&P: BioMarin Pharmaceutical Inc. B- Corporate Credit Rating ...  -  Jun 25, 2008
PharmaLive.com (press release),The company has three main products--Aldurazyme, an enzyme replacement therapy for the treatment of the genetic disease mucopolysaccharidosis I (MPS I);

Steve Glass Appointed Vice President and General Manager, BioMarin  -  Mar 22, 2008
FOXBusinessBioMarin Europe Ltd., headquartered in London, is responsible for the sales and distribution of Naglazyme(R) for MPS VI (mucopolysaccharidosis VI) in Europe

BioMarin Announces Fourth Quarter and Full Year 2007 Financial Results  -  Feb 26, 2008
Earthtimes,Net revenue from Naglazyme(R) (galsulfase), an enzyme replacement therapy for mucopolysaccharidosis VI (MPS VI), was $25.5 million for the fourth quarter of

Dillon couple charged in marijuana bust  -  Mar 13, 2008
Great Falls Tribune,Day has a form of mucopolysaccharidosis, a rare disease in which the body is unable to produce certain enzymes. Day said his symptoms include severe

ACLU provides forum on pain and marijuana  -  Mar 1, 2008
The Missoulian,For the last 12 years, Day said, he has managed unthinkable chronic pain - the result of a degenerative congenital condition called mucopolysaccharidosis

BioMarin to Host Fourth Quarter and Full Year 2007 Financial ...  -  Feb 5, 2008
FOXBusinessApproved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin;

BioMarin Pharmaceutical Inc (BMRN) to Hold Q4 2007 Conference Call ...  -  Feb 14, 2008
TransWorldNews (press release),Aldurazyme is marketed in the United States , European Union , Japan and other countries to treat mucopolysaccharidosis I. The Food and Drug Administration

BioMarin names new sales boss for Europe  -  Jan 22, 2008
Bizjournals.com,Glass will work out of BioMarin's office in London, running sales of Naglazyme, a treatment for mucopolysaccharidosis VI. This is BioMarin's first drug to

Scripps scientists find calcium channel blockers help normalize ...  -  Feb 4, 2008
EurekAlert (press release),People with type IIIA mucopolysaccharidosis have a deficiency in one of the enzymes needed to break down heparan sulfate, which leads to progressive central

Shire's ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment ...  -  Feb 13, 2008
FOXBusinessHunter syndrome, also known as Mucopolysaccharidosis II (MPS II), is a serious, life-threatening genetic condition mainly affecting males that results from

Genzyme Turns To Profit In Q4 On Strong Drug Sales; Guides Q1 ...  -  Feb 13, 2008
RTT News,Sales of Aldurazyme, which is indicated for the treatment of mucopolysaccharidosis I, increased to $34 million from $26 million in the previous-year quarter

River Oaks teen beat odds by living active life  -  Feb 2, 2008
Fort Worth Star Telegram,Doctors estimated that Mucopolysaccharidosis, known as Hurler's syndrome or MPS, would claim the fair-haired boy in a handful of years.

A special space for Hailee  -  Jan 25, 2008
Shelbyville Times-Gazette,Hailee suffers from an extremely rare genetic disorder called Sanfilippo Syndrome: Mucopolysaccharidosis (MPS), an incurable disease that severely limits

Rare diseases rethought with exhibition  -  Jan 25, 2008
Checkbiotech.org (press release),...“I am ten years old and have MPS,? wrote Nicklas Harkins, who suffers from mucopolysaccharidosis and was one of several artists who depicted his disease as

Daughter's illness has family raising money  -  Dec 27, 2007
San Jose Mercury News,Morquio syndrome is a type of mucopolysaccharidosis in which the body does not produce the proper enzyme to break down long chains of glucose.

BioMarin Re-Acquires Rights to Kuvan in Canada From Merck Serono  -  Dec 18, 2007
CNNMoney.comApproved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin;

Life-saving pill puts a spring in Hayleigh’s step  -  Dec 26, 2007
Glasgow Evening Times,Hayleigh, from Barmulloch, Glasgow, has mucopolysaccharidosis, which occurs in infancy and causes progressive physical and mental disability.

Trigger Finger Due to Tenosynovitis From Mycobacterium Kansasii ...  -  Dec 14, 2007
Ortho SuperSite,2 Diffuse tenosynovitis causes include systemic disease such as diabetes mellitus, amyloidosis, mucopolysaccharidosis, infection, and rheumatoid arthritis

More Upside for BMRN  -  Dec 19, 2007
Trading Markets (press release),Its leading product, Aldurazyme, is used for treating the ultra-rare genetic disorder mucopolysaccharidosis-I (MPS-I) while its second product, Naglazyme,

Banking and Finance : Zacks Bull and Bear of the Day Highlights ...  -  Dec 1, 2007
SkyNewswire.com (press release),Its leading product, Aldurazyme, is used for treating the ultra-rare genetic disorder mucopolysaccharidosis-I (MPS-I). The company recently gained FDA and

The Pantagraph (Bloomington, IL) (KRT) - Nov. 26, 2007  -  28 Nov 2007
Therapeutics Daily (subscription) (press release),Sydney has MPS (mucopolysaccharidosis) 1, or Hurler Syndrome, a rare disease that has inhibited her growth and resulted in an original life expectancy of

biomarin Files Investigational New Drug Application for PEG-PAL ...  -  28 Nov 2007
CNNMoney.comApproved products include Naglazyme(R) (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by biomarin,

pictures of hope  -  Nov 18, 2007
Washington Post,..."i am ten years old and have mps," nicklas writes, using shorthand for the disease mucopolysaccharidosis. "my painting of a dragon expresses the courage

biomarin to present at the rodman & renshaw 9th annual healthcare ...  -  Oct 31, 2007
CNNMoney.com...and aldurazyme(r) (laronidase) for mucopolysaccharidosis i (mps i), a product which biomarin developed through a 50/50 joint venture with genzyme

biomarin announces third quarter 2007 financial results  -  Nov 1, 2007
PR Newswire (press release),...product sales net sales of naglazyme(r) (galsulfase), an enzyme replacement therapy for mucopolysaccharidosis vi (mps vi), were $21.3 million for the third

new bedford honor student has aced her biggest test  -  Nov 14, 2007
SouthCoastToday.com,...lauren, 16, suffers from mps vi, a form of the genetic metabolic disease mucopolysaccharidosis, which affects about one out of every 215000 births. those

single gene therapy injection may correct devastating neurological ...  -  Nov 13, 2007
Thaindian.com,...the journal of neuroscience. the mice used in the study were specially bred to have the neurogenetic disease mucopolysaccharidosis type vii (mps vii),

paladin reports 2007 record third quarter financial results  -  Nov 1, 2007
Market Wire (press release)...to include elaprase tm , indicated for enzyme replacement therapy in patients with hunter syndrome (mucopolysaccharidosis ii, mps ii). hunter syndrome



Background information on [an error occurred while processing this directive]

Background information on Mucopolysaccharidosis [When available]

[When available]



Search the web for more resources on Mucopolysaccharidosis



Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy